在诱导化疗后,在鼻癌患者中确定客观反应的最佳切断值

Chao Luo1, Wenjie Huang1, Shuqi Li1

  • 1Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Head & neck
|March 28, 2024
PubMed
概括

固体瘤响应评估标准 (RECIST) 1.1 20%的门比标准的30%客观响应 (OR) 截止值更好地预测鼻癌 (NPC) 患者的远程无转移生存率. 这一发现有助于更准确地评估NPC的治疗反应.